BetterLife Pharma (BETRF) Exchange Rate Effect (2019 - 2026)
BetterLife Pharma (BETRF) posted quarterly Exchange Rate Effect of $131.31 for Q2 2026, up 196.6% year-over-year from $44.27 in Q2 2025, and down 62.1% quarter-over-quarter from $346.43 in Q3 2025.
BetterLife Pharma (BETRF) Exchange Rate Effect (2019 - 2026) Analysis & Trends
BetterLife Pharma's Exchange Rate Effect history runs 8 years deep, the most recent figure standing at $131.31 for Q2 2026.
- In Q2 2026, Exchange Rate Effect rose 196.6% year-over-year to $131.31; the TTM figure through Apr 2026 stood at $519.19 (up 981.22% YoY), while the FY2026 annual figure was $419.37, up 7341.72% from the prior year.
- Exchange Rate Effect for Q2 2026 stood at $131.31, down from $346.43 in the prior quarter.
- The five-year high for Exchange Rate Effect was $35.4 million in Q4 2022, with the low at -$34.8 million in Q1 2023.
- The 5-year median for Exchange Rate Effect is -$0.3 (2024), against an average of $33277.0.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect jumped 260274.68% in 2022, then plunged 341136.85% in 2023.
- BetterLife Pharma's Exchange Rate Effect stood at $35.4 million in 2022, then slumped by 100.0% to $72.27 in 2023, then tumbled by 104.05% to -$2.93 in 2024, then surged by 11926.82% to $346.43 in 2025, then sank by 62.1% to $131.31 in 2026.
- Business Quant data shows BETRF's Exchange Rate Effect at $131.31 in Q2 2026, $346.43 in Q3 2025, and $44.27 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -2.45 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -287,000.00 |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.63 Mn |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 131.31 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 131.31 |
| Apr 30, 2026 | 131.31 |
| Jul 31, 2025 | 346.43 |
| Jul 31, 2025 | 346.43 |
| Apr 30, 2025 | 44.27 |
| Apr 30, 2025 | 44.27 |
| Jan 31, 2025 | -2.82 |
| Jan 31, 2025 | -2.82 |
| Oct 31, 2024 | -2.93 |
| Oct 31, 2024 | -2.93 |
| Jul 31, 2024 | 9.49 |
| Jul 31, 2024 | 9.49 |
| Apr 30, 2024 | 2.21 |
| Apr 30, 2024 | 2.21 |
| Jan 31, 2024 | -76.19 |
| Jan 31, 2024 | -76.19 |
| Oct 31, 2023 | 72.27 |
| Oct 31, 2023 | 72.27 |
| Jul 31, 2023 | -10.49 |
| Jul 31, 2023 | -10.49 |